表紙
市場調查報告書

肺炎球菌疫苗的全球市場:未來展望

Global Pneumonia Vaccines Market (2019-2025)

出版商 KBV Research 商品編碼 888286
出版日期 內容資訊 英文 243 Pages
訂單完成後即時交付
價格
Back to Top
肺炎球菌疫苗的全球市場:未來展望 Global Pneumonia Vaccines Market (2019-2025)
出版日期: 2019年06月30日內容資訊: 英文 243 Pages
簡介

本報告提供全球肺炎球菌疫苗的市場相關分析,疾病、產品概要和市場主要趨勢,市場規模趨勢預測 (今後7年份),疫苗的各類型、各產品種類、各部門、各流通管道及各地區詳細趨勢,主要的推動及阻礙市場要素,市場競爭環境,主要企業的簡介和策略展開情形等相關調查。

第1章 市場範圍和分析方法

第2章 市場概要

  • 簡介
  • 市場主要影響要素
    • 推動市場要素
    • 阻礙市場要素

第3章 全球肺炎球菌疫苗市場:疫苗的各類型

  • 結合型肺炎球菌疫苗 (PCV)
  • 肺炎球菌多糖類疫苗 (PPSV/PPV)

第4章 全球肺炎球菌疫苗市場:各產品種類

  • Prevnar 13
  • Synflorix
  • Pneumovax 23

第5章 全球肺炎球菌疫苗市場:各部門

  • 民間部門
  • 公共部門

第6章 全球肺炎球菌疫苗市場:各流通管道

  • 銷售合作夥伴
  • NGO (非官方機構)
  • 政府當局

第7章 全球肺炎球菌疫苗市場:各地區

  • 北美市場 (美國,加拿大,墨西哥等)
    • 疫苗的各類型
    • 各產品種類
    • 各部門
    • 各流通管道
    • 各國分析
  • 歐洲市場 (德國,英國,法國,俄羅斯,西班牙,義大利等)
  • 亞太地區市場 (中國,日本,印度,韓國,新加坡,馬來西亞等)
  • 南美、中東、非洲市場 (LAMEA:巴西,阿根廷,UAE,沙烏地阿拉伯,南非,奈及利亞等)

第8章 企業簡介

  • GLAXOSMITHKLINE PLC (GSK)
    • 企業概要
    • 財務分析
    • 各領域、各地區分析
    • 研究開發 (R&D) 費用
    • 近幾年的策略展開趨勢
    • SWOT分析
  • LG Corporation (LG Chemicals Ltd.)
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • PnuVax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
  • Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
  • SK Holdings Co., Ltd. (SK Bioscience, Inc.)
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
目錄

The Global Pneumonia Vaccines Market size is expected to reach $9.6 billion by 2025, rising at a market growth of 5.1% CAGR during the forecast period.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs thereby filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at the greatest risk of serious pneumococcal infections and even death. Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs.

The key factors that drive the growth of the global pneumonia vaccine market include an increase in the prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with the development of such vaccines restrain the market growth.

Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. And MERCK & CO., Inc.

Scope of the Study

Market Segmentation:

By Vaccine Type

  • Pneumococcal conjugate vaccine (PCV)
  • Pneumococcal polysaccharide vaccine (PPSV/PPV)

By Product Type

  • Prevnar 13
  • Synflorix
  • Pneumovax23

By Sector

  • Public sector
  • Private sector

By Distribution Channel

  • Distribution partner companies
  • Non-governmental Organizations (NGO)
  • Government Authorities

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Pneumonia Vaccines Market, by Vaccine Type
    • 1.4.2 Global Pneumonia Vaccines Market, by Product Type
    • 1.4.3 Global Pneumonia Vaccines Market, by Sector
    • 1.4.4 Global Pneumonia Vaccines Market, by Distribution Channel
    • 1.4.5 Global Pneumonia Vaccines Market, by Region
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Pneumonia Vaccines Market by Vaccine Type

  • 3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market by Region
  • 3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region

Chapter 4. Global Pneumonia Vaccines Market by Product Type

  • 4.1 Global Prevnar 13 Market by Region
  • 4.2 Global Synflorix Market by Region
  • 4.3 Global Pneumovax 23 Market by Region

Chapter 5. Global Pneumonia Vaccines Market by Sector

  • 5.1 Global Private sector Market by Region
  • 5.2 Global Public sector Market by Region

Chapter 6. Global Pneumonia Vaccines Market by Distribution Channel

  • 6.1 Global Distribution Partner Companies Market by Region
  • 6.2 Global Non-Governmental Organizations (NGO) Market by Region
  • 6.3 Global Government Authorities Market by Region

Chapter 7. Global Pneumonia Vaccines Market by Region

  • 7.1 North America Pneumonia Vaccines Market
    • 7.1.1 North America Pneumonia Vaccines Market by Vaccine Type
      • 7.1.1.1 North America Pneumococcal Conjugate Vaccine (PCV) Market by Region
      • 7.1.1.2 North America Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
    • 7.1.2 North America Pneumonia Vaccines Market by Product Type
      • 7.1.2.1 North America Prevnar 13 Market by Region
      • 7.1.2.2 North America Synflorix Market by Region
      • 7.1.2.3 North America Pneumovax 23 Market by Region
    • 7.1.3 North America Pneumonia Vaccines Market by Sector
      • 7.1.3.1 North America Private sector Market by Region
      • 7.1.3.2 North America Public sector Market by Region
    • 7.1.4 North America Pneumonia Vaccines Market by Distribution Channel
      • 7.1.4.1 North America Distribution Partner Companies Market by Region
      • 7.1.4.2 North America Non-Governmental Organizations (NGO) Market by Region
      • 7.1.4.3 North America Government Authorities Market by Region
    • 7.1.5 North America Pneumonia Vaccines Market by Region
      • 7.1.5.1 USA Pneumonia Vaccines Market
        • 7.1.5.1.1 USA Pneumonia Vaccines Market by Vaccine Type
        • 7.1.5.1.2 USA Pneumonia Vaccines Market by Product Type
        • 7.1.5.1.3 USA Pneumonia Vaccines Market by Sector
        • 7.1.5.1.4 USA Pneumonia Vaccines Market by Distribution Channel
      • 7.1.5.2 Canada Pneumonia Vaccines Market
        • 7.1.5.2.1 Canada Pneumonia Vaccines Market by Vaccine Type
        • 7.1.5.2.2 Canada Pneumonia Vaccines Market by Product Type
        • 7.1.5.2.3 Canada Pneumonia Vaccines Market by Sector
        • 7.1.5.2.4 Canada Pneumonia Vaccines Market by Distribution Channel
      • 7.1.5.3 Mexico Pneumonia Vaccines Market
        • 7.1.5.3.1 Mexico Pneumonia Vaccines Market by Vaccine Type
        • 7.1.5.3.2 Mexico Pneumonia Vaccines Market by Product Type
        • 7.1.5.3.3 Mexico Pneumonia Vaccines Market by Sector
        • 7.1.5.3.4 Mexico Pneumonia Vaccines Market by Distribution Channel
      • 7.1.5.4 Rest of North America Pneumonia Vaccines Market
        • 7.1.5.4.1 Rest of North America Pneumonia Vaccines Market by Vaccine Type
        • 7.1.5.4.2 Rest of North America Pneumonia Vaccines Market by Product Type
        • 7.1.5.4.3 Rest of North America Pneumonia Vaccines Market by Sector
        • 7.1.5.4.4 Rest of North America Pneumonia Vaccines Market by Distribution Channel
  • 7.2 Europe Pneumonia Vaccines Market
    • 7.2.1 Europe Pneumonia Vaccines Market by Vaccine Type
      • 7.2.1.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market by Region
      • 7.2.1.2 Europe Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
    • 7.2.2 Europe Pneumonia Vaccines Market by Product Type
      • 7.2.2.1 Europe Prevnar 13 Market by Region
      • 7.2.2.2 Europe Synflorix Market by Region
      • 7.2.2.3 Europe Pneumovax 23 Market by Region
    • 7.2.3 Europe Pneumonia Vaccines Market by Sector
      • 7.2.3.1 Europe Private sector Market by Region
      • 7.2.3.2 Europe Public sector Market by Region
    • 7.2.4 Europe Pneumonia Vaccines Market by Distribution Channel
      • 7.2.4.1 Europe Distribution Partner Companies Market by Region
      • 7.2.4.2 Europe Non-Governmental Organizations (NGO) Market by Region
      • 7.2.4.3 Europe Government Authorities Market by Region
    • 7.2.5 Europe Pneumonia Vaccines Market by Region
      • 7.2.5.1 Germany Pneumonia Vaccines Market
        • 7.2.5.1.1 Germany Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.1.2 Germany Pneumonia Vaccines Market by Product Type
        • 7.2.5.1.3 Germany Pneumonia Vaccines Market by Sector
        • 7.2.5.1.4 Germany Pneumonia Vaccines Market by Distribution Channel
      • 7.2.5.2 UK Pneumonia Vaccines Market
        • 7.2.5.2.1 UK Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.2.2 UK Pneumonia Vaccines Market by Product Type
        • 7.2.5.2.3 UK Pneumonia Vaccines Market by Sector
        • 7.2.5.2.4 UK Pneumonia Vaccines Market by Distribution Channel
      • 7.2.5.3 France Pneumonia Vaccines Market
        • 7.2.5.3.1 France Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.3.2 France Pneumonia Vaccines Market by Product Type
        • 7.2.5.3.3 France Pneumonia Vaccines Market by Sector
        • 7.2.5.3.4 France Pneumonia Vaccines Market by Distribution Channel
      • 7.2.5.4 Russia Pneumonia Vaccines Market
        • 7.2.5.4.1 Russia Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.4.2 Russia Pneumonia Vaccines Market by Product Type
        • 7.2.5.4.3 Russia Pneumonia Vaccines Market by Sector
        • 7.2.5.4.4 Russia Pneumonia Vaccines Market by Distribution Channel
      • 7.2.5.5 Spain Pneumonia Vaccines Market
        • 7.2.5.5.1 Spain Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.5.2 Spain Pneumonia Vaccines Market by Product Type
        • 7.2.5.5.3 Spain Pneumonia Vaccines Market by Sector
        • 7.2.5.5.4 Spain Pneumonia Vaccines Market by Distribution Channel
      • 7.2.5.6 Italy Pneumonia Vaccines Market
        • 7.2.5.6.1 Italy Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.6.2 Italy Pneumonia Vaccines Market by Product Type
        • 7.2.5.6.3 Italy Pneumonia Vaccines Market by Sector
        • 7.2.5.6.4 Italy Pneumonia Vaccines Market by Distribution Channel
      • 7.2.5.7 Rest of Europe Pneumonia Vaccines Market
        • 7.2.5.7.1 Rest of Europe Pneumonia Vaccines Market by Vaccine Type
        • 7.2.5.7.2 Rest of Europe Pneumonia Vaccines Market by Product Type
        • 7.2.5.7.3 Rest of Europe Pneumonia Vaccines Market by Sector
        • 7.2.5.7.4 Rest of Europe Pneumonia Vaccines Market by Distribution Channel
  • 7.3 Asia Pacific Pneumonia Vaccines Market
    • 7.3.1 Asia Pacific Pneumonia Vaccines Market by Type
      • 7.3.1.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market by Region
      • 7.3.1.2 Asia Pacific Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
    • 7.3.2 Asia Pacific Pneumonia Vaccines Market by Product Type
      • 7.3.2.1 Asia Pacific Prevnar 13 Market by Region
      • 7.3.2.2 Asia Pacific Synflorix Market by Region
      • 7.3.2.3 Asia Pacific Pneumovax 23 Market by Region
    • 7.3.3 Asia Pacific Pneumonia Vaccines Market by Sector
      • 7.3.3.1 Asia Pacific Public sector Market by Region
      • 7.3.3.2 Asia Pacific Private sector Market by Region
    • 7.3.4 Asia Pacific Pneumonia Vaccines Market by Distribution Channel
      • 7.3.4.1 Asia Pacific Distribution Partner Companies Market by Region
      • 7.3.4.2 Asia Pacific Non-Governmental Organizations (NGO) Market by Region
      • 7.3.4.3 Asia Pacific Government Authorities Market by Region
    • 7.3.5 Asia Pacific Pneumonia Vaccines Market by Region
      • 7.3.5.1 China Pneumonia Vaccines Market
        • 7.3.5.1.1 China Pneumonia Vaccines Market by Type
        • 7.3.5.1.2 China Pneumonia Vaccines Market by Product Type
        • 7.3.5.1.3 China Pneumonia Vaccines Market by Sector
        • 7.3.5.1.4 China Pneumonia Vaccines Market by Distribution Channel
      • 7.3.5.2 Japan Pneumonia Vaccines Market
        • 7.3.5.2.1 Japan Pneumonia Vaccines Market by Type
        • 7.3.5.2.2 Japan Pneumonia Vaccines Market by Product Type
        • 7.3.5.2.3 Japan Pneumonia Vaccines Market by Sector
        • 7.3.5.2.4 Japan Pneumonia Vaccines Market by Distribution Channel
      • 7.3.5.3 India Pneumonia Vaccines Market
        • 7.3.5.3.1 India Pneumonia Vaccines Market by Type
        • 7.3.5.3.2 India Pneumonia Vaccines Market by Product Type
        • 7.3.5.3.3 India Pneumonia Vaccines Market by Sector
        • 7.3.5.3.4 India Pneumonia Vaccines Market by Distribution Channel
      • 7.3.5.4 South Korea Pneumonia Vaccines Market
        • 7.3.5.4.1 South Korea Pneumonia Vaccines Market by Type
        • 7.3.5.4.2 South Korea Pneumonia Vaccines Market by Product Type
        • 7.3.5.4.3 South Korea Pneumonia Vaccines Market by Sector
        • 7.3.5.4.4 South Korea Pneumonia Vaccines Market by Distribution Channel
      • 7.3.5.5 Singapore Pneumonia Vaccines Market
        • 7.3.5.5.1 Singapore Pneumonia Vaccines Market by Type
        • 7.3.5.5.2 Singapore Pneumonia Vaccines Market by Product Type
        • 7.3.5.5.3 Singapore Pneumonia Vaccines Market by Sector
        • 7.3.5.5.4 Singapore Pneumonia Vaccines Market by Distribution Channel
      • 7.3.5.6 Malaysia Pneumonia Vaccines Market
        • 7.3.5.6.1 Malaysia Pneumonia Vaccines Market by Type
        • 7.3.5.6.2 Malaysia Pneumonia Vaccines Market by Product Type
        • 7.3.5.6.3 Malaysia Pneumonia Vaccines Market by Sector
        • 7.3.5.6.4 Malaysia Pneumonia Vaccines Market by Distribution Channel
      • 7.3.5.7 Rest of Asia Pacific Pneumonia Vaccines Market
        • 7.3.5.7.1 Rest of Asia Pacific Pneumonia Vaccines Market by Type
        • 7.3.5.7.2 Rest of Asia Pacific Pneumonia Vaccines Market by Product Type
        • 7.3.5.7.3 Rest of Asia Pacific Pneumonia Vaccines Market by Sector
        • 7.3.5.7.4 Rest of Asia Pacific Pneumonia Vaccines Market by Distribution Channel
  • 7.4 LAMEA Pneumonia Vaccines Market
    • 7.4.1 LAMEA Pneumonia Vaccines Market by Vaccine Type
      • 7.4.1.1 LAMEA Pneumococcal Conjugate Vaccine (PCV) Market by Region
      • 7.4.1.2 LAMEA Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
    • 7.4.2 LAMEA Pneumonia Vaccines Market by Product Type
      • 7.4.2.1 LAMEA Prevnar 13 Market by Region
      • 7.4.2.2 LAMEA Synflorix Market by Region
      • 7.4.2.3 LAMEA Pneumovax 23 Market by Region
    • 7.4.3 LAMEA Pneumonia Vaccines Market by Sector
      • 7.4.3.1 LAMEA Private sector Market by Region
      • 7.4.3.2 LAMEA Public sector Market by Region
    • 7.4.4 LAMEA Pneumonia Vaccines Market by Distribution Channel
      • 7.4.4.1 LAMEA Distribution Partner Companies Market by Region
      • 7.4.4.2 LAMEA Non-Governmental Organizations (NGO) Market by Region
      • 7.4.4.3 LAMEA Government Authorities Market by Region
    • 7.4.5 LAMEA Pneumonia Vaccines Market by Region
      • 7.4.5.1 Brazil Pneumonia Vaccines Market
        • 7.4.5.1.1 Brazil Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.1.2 Brazil Pneumonia Vaccines Market by Product Type
        • 7.4.5.1.3 Brazil Pneumonia Vaccines Market by Sector
        • 7.4.5.1.4 Brazil Pneumonia Vaccines Market by Distribution Channel
      • 7.4.5.2 Argentina Pneumonia Vaccines Market
        • 7.4.5.2.1 Argentina Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.2.2 Argentina Pneumonia Vaccines Market by Product Type
        • 7.4.5.2.3 Argentina Pneumonia Vaccines Market by Sector
        • 7.4.5.2.4 Argentina Pneumonia Vaccines Market by Distribution Channel
      • 7.4.5.3 UAE Pneumonia Vaccines Market
        • 7.4.5.3.1 UAE Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.3.2 UAE Pneumonia Vaccines Market by Product Type
        • 7.4.5.3.3 UAE Pneumonia Vaccines Market by Sector
        • 7.4.5.3.4 UAE Pneumonia Vaccines Market by Distribution Channel
      • 7.4.5.4 Saudi Arabia Pneumonia Vaccines Market
        • 7.4.5.4.1 Saudi Arabia Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.4.2 Saudi Arabia Pneumonia Vaccines Market by Product Type
        • 7.4.5.4.3 Saudi Arabia Pneumonia Vaccines Market by Sector
        • 7.4.5.4.4 Saudi Arabia Pneumonia Vaccines Market by Distribution Channel
      • 7.4.5.5 South Africa Pneumonia Vaccines Market
        • 7.4.5.5.1 South Africa Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.5.2 South Africa Pneumonia Vaccines Market by Product Type
        • 7.4.5.5.3 South Africa Pneumonia Vaccines Market by Sector
        • 7.4.5.5.4 South Africa Pneumonia Vaccines Market by Distribution Channel
      • 7.4.5.6 Nigeria Pneumonia Vaccines Market
        • 7.4.5.6.1 Nigeria Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.6.2 Nigeria Pneumonia Vaccines Market by Product Type
        • 7.4.5.6.3 Nigeria Pneumonia Vaccines Market by Sector
        • 7.4.5.6.4 Nigeria Pneumonia Vaccines Market by Distribution Channel
      • 7.4.5.7 Rest of LAMEA Pneumonia Vaccines Market
        • 7.4.5.7.1 Rest of LAMEA Pneumonia Vaccines Market by Vaccine Type
        • 7.4.5.7.2 Rest of LAMEA Pneumonia Vaccines Market by Product Type
        • 7.4.5.7.3 Rest of LAMEA Pneumonia Vaccines Market by Sector
        • 7.4.5.7.4 Rest of LAMEA Pneumonia Vaccines Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 GLAXOSMITHKLINE PLC (GSK)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.1 Recent strategies and developments:
      • 8.1.1.1 Collaboration, partnerships and agreements:
      • 8.1.1.2 Expansion:
    • 8.1.2 SWOT Analysis
  • 8.2 LG Corporation (LG Chemicals Ltd.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Panacea Biotec Limited
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Collaboration, partnerships and agreements:
    • 8.3.6 SWOT Analysis
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Collaboration, partnerships and agreements:
      • 8.4.5.2 Product launch:
    • 8.4.6 SWOT Analysis
  • 8.5 PnuVax Incorporated
    • 8.5.1 Company Overview
  • 8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
    • 8.6.1 Company Overview
  • 8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
    • 8.7.1 Company Overview
  • 8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
    • 8.8.1 Company overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
  • 8.9 Walvax Biotechnology Co., Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Recent strategies and developments:
      • 8.9.2.1 Product launch:
  • 8.1 Merck & Co., Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Collaboration, partnerships and agreements:
      • 8.10.5.2 Product launch:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1: GLOBAL PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 2: GLOBAL PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
  • TABLE 3: GLOBAL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 4: GLOBAL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 5: GLOBAL PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6: GLOBAL PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7: GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8: GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9: GLOBAL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 10: GLOBAL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 11: GLOBAL PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12: GLOBAL PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13: GLOBAL SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14: GLOBAL SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15: GLOBAL PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 16: GLOBAL PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 17: GLOBAL PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 18: GLOBAL PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 19: GLOBAL PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20: GLOBAL PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21: GLOBAL PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22: GLOBAL PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23: GLOBAL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 24: GLOBAL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 25: GLOBAL DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26: GLOBAL DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27: GLOBAL NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 28: GLOBAL NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 29: GLOBAL GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30: GLOBAL GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31: GLOBAL PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32: GLOBAL PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33: NORTH AMERICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 34: NORTH AMERICA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
  • TABLE 35: NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 36: NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 37: NORTH AMERICA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 38: NORTH AMERICA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 39: NORTH AMERICA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 40: NORTH AMERICA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 41: NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 42: NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 43: NORTH AMERICA PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 44: NORTH AMERICA PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 45: NORTH AMERICA SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 46: NORTH AMERICA SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 47: NORTH AMERICA PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 48: NORTH AMERICA PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 49: NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 50: NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 51: NORTH AMERICA PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 52: NORTH AMERICA PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 53: NORTH AMERICA PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 54: NORTH AMERICA PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 55: NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 56: NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 57: NORTH AMERICA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 58: NORTH AMERICA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 59: NORTH AMERICA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 60: NORTH AMERICA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 61: NORTH AMERICA GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 62: NORTH AMERICA GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 63: NORTH AMERICA PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 64: NORTH AMERICA PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 65: USA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 66: USA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
  • TABLE 67: USA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 68: USA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 69: USA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 70: USA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 71: USA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 72: USA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 73: USA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 74: USA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 75: CANADA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 76: CANADA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
  • TABLE 77: CANADA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 78: CANADA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 79: CANADA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 80: CANADA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 81: CANADA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 82: CANADA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 83: CANADA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 84: CANADA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 85: MEXICO PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 86: MEXICO PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
  • TABLE 87: MEXICO PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 88: MEXICO PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 89: MEXICO PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 90: MEXICO PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 91: MEXICO PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 92: MEXICO PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 93: MEXICO PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 94: MEXICO PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 95: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 96: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
  • TABLE 97: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 98: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 99: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 100: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 101: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 102: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 103: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 104: REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 105: EUROPE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 106: EUROPE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 107: EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 108: EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 109: EUROPE PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 110: EUROPE PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 111: EUROPE PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 112: EUROPE PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 113: EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 114: EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 115: EUROPE PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 116: EUROPE PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 117: EUROPE SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 118: EUROPE SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 119: EUROPE PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 120: EUROPE PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 121: EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 122: EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 123: EUROPE PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 124: EUROPE PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 125: EUROPE PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 126: EUROPE PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 127: EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 128: EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 129: EUROPE DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 130: EUROPE DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 131: EUROPE NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 132: EUROPE NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 133: EUROPE GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 134: EUROPE GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 135: EUROPE PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 136: EUROPE PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 137: GERMANY PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 138: GERMANY PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 139: GERMANY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 140: GERMANY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 141: GERMANY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 142: GERMANY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 143: GERMANY PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 144: GERMANY PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 145: GERMANY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 146: GERMANY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 147: UK PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 148: UK PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 149: UK PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 150: UK PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 151: UK PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 152: UK PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 153: UK PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 154: UK PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 155: UK PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 156: UK PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 157: FRANCE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 158: FRANCE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 159: FRANCE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 160: FRANCE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 161: FRANCE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 162: FRANCE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 163: FRANCE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 164: FRANCE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 165: FRANCE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 166: FRANCE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 167: RUSSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 168: RUSSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 169: RUSSIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 170: RUSSIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 171: RUSSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 172: RUSSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 173: RUSSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 174: RUSSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 175: RUSSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 176: RUSSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 177: SPAIN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 178: SPAIN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 179: SPAIN PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 180: SPAIN PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 181: SPAIN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 182: SPAIN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 183: SPAIN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 184: SPAIN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 185: SPAIN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 186: SPAIN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 187: ITALY PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 188: ITALY PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 189: ITALY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 190: ITALY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 191: ITALY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 192: ITALY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 193: ITALY PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 194: ITALY PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 195: ITALY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 196: ITALY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 197: REST OF EUROPE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 198: REST OF EUROPE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 199: REST OF EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 200: REST OF EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 201: REST OF EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 202: REST OF EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 203: REST OF EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 204: REST OF EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 205: REST OF EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 206: REST OF EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 207: ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 208: ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 209: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 210: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 211: ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 212: ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 213: ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 214: ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 215: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 216: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 217: ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 218: ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 219: ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 220: ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 221: ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 222: ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 223: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 224: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 225: ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 226: ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 227: ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 228: ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 229: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 230: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 231: ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 232: ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 233: ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 234: ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 235: ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 236: ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 237: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 238: ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 239: CHINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 240: CHINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 241: CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 242: CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 243: CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 244: CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 245: CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 246: CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 247: CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 248: CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 249: JAPAN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 250: JAPAN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 251: JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 252: JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 253: JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 254: JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 255: JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 256: JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 257: JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 258: JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 259: INDIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 260: INDIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 261: INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 262: INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 263: INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 264: INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 265: INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 266: INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 267: INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 268: INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 269: SOUTH KOREA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 270: SOUTH KOREA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 271: SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 272: SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 273: SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 274: SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 275: SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 276: SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 277: SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 278: SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 279: SINGAPORE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 280: SINGAPORE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 281: SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 282: SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 283: SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 284: SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 285: SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 286: SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 287: SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 288: SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 289: MALAYSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 290: MALAYSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 291: MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 292: MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 293: MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 294: MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 295: MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 296: MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 297: MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 298: MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 299: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 300: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 301: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 302: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 303: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 304: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 305: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 306: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 307: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 308: REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 309: LAMEA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 310: LAMEA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 311: LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 312: LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 313: LAMEA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 314: LAMEA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 315: LAMEA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 316: LAMEA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 317: LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 318: LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 319: LAMEA PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 320: LAMEA PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 321: LAMEA SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 322: LAMEA SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 323: LAMEA PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 324: LAMEA PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 325: LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 326: LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 327: LAMEA PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 328: LAMEA PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 329: LAMEA PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 330: LAMEA PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 331: LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 332: LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 333: LAMEA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 334: LAMEA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 335: LAMEA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 336: LAMEA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 337: LAMEA GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 338: LAMEA GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 339: LAMEA PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 340: LAMEA PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 341: BRAZIL PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 342: BRAZIL PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 343: BRAZIL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 344: BRAZIL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 345: BRAZIL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 346: BRAZIL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 347: BRAZIL PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 348: BRAZIL PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 349: BRAZIL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 350: BRAZIL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 351: ARGENTINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 352: ARGENTINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 353: ARGENTINA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 354: ARGENTINA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 355: ARGENTINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 356: ARGENTINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 357: ARGENTINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 358: ARGENTINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 359: ARGENTINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 360: ARGENTINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 361: UAE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 362: UAE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 363: UAE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 364: UAE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 365: UAE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 366: UAE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 367: UAE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 368: UAE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 369: UAE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 370: UAE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 371: SAUDI ARABIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 372: SAUDI ARABIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 373: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 374: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 375: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 376: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 377: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 378: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 379: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 380: SAUDI ARABIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 381: SOUTH AFRICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 382: SOUTH AFRICA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 383: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 384: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 385: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 386: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 387: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 388: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 389: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 390: SOUTH AFRICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 391: NIGERIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 392: NIGERIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 393: NIGERIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 394: NIGERIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 395: NIGERIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 396: NIGERIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 397: NIGERIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 398: NIGERIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 399: NIGERIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 400: NIGERIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 401: REST OF LAMEA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 402: REST OF LAMEA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 403: REST OF LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 404: REST OF LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 405: REST OF LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 406: REST OF LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 407: REST OF LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 408: REST OF LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 409: REST OF LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 410: REST OF LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 411: KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 412: KEY INFORMATION - LG CORPORATION
  • TABLE 413: KEY INFORMATION - PANACEA BIOTEC LIMITED
  • TABLE 414: KEY INFORMATION - PFIZER, INC.
  • TABLE 415: KEY INFORMATION - PNUVAX INCORPORATED
  • TABLE 416: KEY INFORMATION - POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
  • TABLE 417: KEY INFORMATION - SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
  • TABLE 418: KEY INFORMATION - SK HOLDINGS CO., LTD.
  • TABLE 419: KEY INFORMATION - WALVAX BIOTECHNOLOGY CO., LTD.
  • TABLE 420: KEY INFORMATION - MERCK & CO., INC.

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
Back to Top